Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
CONTRAFECT Corp (CFRX)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2022 | GILMAN STEVEN C | Director | Grant | Options (Right to Buy) | 42k | $3.35 | $140.7k | | 05/17/2022 |
| 05/17/2022 | OTTO MICHAEL J. | Director | Grant | Options (Right to Buy) | 42k | $3.35 | $140.7k | | 05/17/2022 |
| 05/17/2022 | Sucoff Cary | Director | Grant | Options (Right to Buy) | 42k | $3.35 | $140.7k | | 05/17/2022 |
| 05/17/2022 | Aklog Lishan | Director | Grant | Options (Right to Buy) | 42k | $3.35 | $140.7k | | 05/17/2022 |
| 05/17/2022 | Low David N. | Director | Grant | Options (Right to Buy) | 42k | $3.35 | $140.7k | | 05/17/2022 |
| 05/17/2022 | Barlow Jane F | Director | Grant | Options (Right to Buy) | 42k | $3.35 | $140.7k | | 05/17/2022 |
| 02/15/2022 | Messinger Michael | CFO | Grant | Options (Right to Buy) | 165k | $3.33 | $549.4k | | 02/15/2022 |
| 02/15/2022 | Bogdanos Natalie | General Counsel | Grant | Options (Right to Buy) | 125k | $3.33 | $416.2k | | 02/15/2022 |
| 02/15/2022 | Pomerantz Roger | CEO | Grant | Options (Right to Buy) | 500k | $3.33 | $1.7M | | 02/15/2022 |
| 02/15/2022 | Cassino Cara M | Chief Medical Officer | Grant | Options (Right to Buy) | 160k | $3.33 | $532.8k | | 02/15/2022 |
| 05/18/2021 | Aklog Lishan | Director | Grant | Options (Right to Buy) | 25k | $3.86 | $96.5k | | 05/18/2021 |
| 05/18/2021 | Low David N. | Director | Grant | Options (Right to Buy) | 25k | $3.86 | $96.5k | | 05/18/2021 |
| 05/18/2021 | BARER SOL J | Director | Grant | Options (Right to Buy) | 25k | $3.86 | $96.5k | | 05/18/2021 |
| 05/18/2021 | Sucoff Cary | Director | Grant | Options (Right to Buy) | 25k | $3.86 | $96.5k | | 05/18/2021 |
| 05/18/2021 | OTTO MICHAEL J. | Director | Grant | Options (Right to Buy) | 25k | $3.86 | $96.5k | | 05/18/2021 |
| 05/18/2021 | GILMAN STEVEN C | Director | Grant | Options (Right to Buy) | 25k | $3.86 | $96.5k | | 05/18/2021 |
| 04/08/2021 | Bogdanos Natalie | General Counsel | Grant | Options (Right to Buy) | 70k | $4.31 | $301.7k | | 04/08/2021 |
| 04/08/2021 | Pomerantz Roger | CEO | Grant | Options (Right to Buy) | 254k | $4.31 | $1.1M | | 04/08/2021 |
| 04/08/2021 | Cassino Cara M | Chief Medical Officer | Grant | Options (Right to Buy) | 80k | $4.31 | $344.8k | | 04/08/2021 |
| 04/08/2021 | Cassino Cara M | Chief Medical Officer | Grant | Options (Right to Buy) | 90k | $4.31 | $387.9k | | 04/08/2021 |
| 04/08/2021 | Messinger Michael | CFO | Grant | Options (Right to Buy) | 80k | $4.31 | $344.8k | | 04/08/2021 |
| 02/08/2021 | Barlow Jane F | Director | Grant | OPTIONS (RIGHT TO BUY) | 16k | $5.89 | $94.2k | | 02/08/2021 |
| 06/15/2020 | Aklog Lishan | Director | Grant | Options (Right to Buy) | 16k | $5.77 | $92.3k | | 06/15/2020 |
| 06/11/2020 | Messinger Michael | CFO | Grant | Options (Right to Buy) | 75k | $5.23 | $392.2k | | 06/11/2020 |
| 12/13/2019 | Low David N. | Director | Purchase | Common Stock, par value $0.0001 per share | 300k | $0.43 | $129k | | 12/13/2019 |
| 12/13/2019 | Messinger Michael | CFO | Purchase | Common Stock, par value $0.0001 per share | 5k | $0.37 | $1.8k | | 12/13/2019 |
| 12/13/2019 | Sucoff Cary | Director | Purchase | Common Stock, par value $0.0001 per share | 50k | $0.39 | $19.5k | | 12/13/2019 |
| 12/04/2018 | Fosun Industrial Co., Ltd | 10% Owner | Sale | Common Stock | 600k | $2.04 | $1.2M | | 12/04/2018 |
| 12/04/2018 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | Sale | Common Stock | 600k | $2.04 | $1.2M | by Fosun Industrial Co., Limited | 12/04/2018 |
| 07/25/2017 | Messinger Michael | CFO | Purchase | Common Stock, par value $0.0001 per share | 800 | $1.24 | $992 | | 07/25/2017 |
| 07/25/2017 | Cassino Cara M | Chief Medical Officer | Purchase | Common Stock, par value $0.0001 per share | 8k | $1.24 | $9.9k | | 07/25/2017 |
| 07/25/2017 | Cassino Cara M | Chief Medical Officer | Purchase | Warrants (Right to Buy) | 4k | $1.55 | $6.2k | | 07/25/2017 |
| 07/25/2017 | Low David N. | Director | Purchase | Common Stock, par value $0.0001 per share | 40k | $1.24 | $49.6k | | 07/25/2017 |
| 07/25/2017 | Low David N. | Director | Purchase | Warrants (Right to Buy) | 20k | $1.55 | $31k | | 07/25/2017 |
| 07/25/2017 | Pomerantz Roger | CEO | Purchase | Common Stock, par value $0.0001 per share | 800 | $1.24 | $992 | | 07/25/2017 |
|
|